Compile Data Set for Download or QSAR
Report error Found 16 of ic50 for UniProtKB: P22607
TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436200(US10590109, Compound 25 | US10590109, Compound 18)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436192(US10590109, Compound 10)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436199(US10590109, Compound 17)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436208(US10590109, Compound 26)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436191(US10590109, Compound 9)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436198(US10590109, Compound 16)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436200(US10590109, Compound 25 | US10590109, Compound 18)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436206(US10590109, Compound 24)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436205(US10590109, Compound 22)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436196(US10590109, Compound 14)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436203(US10590109, Compound 21)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436195(US10590109, Compound 13)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436197(US10590109, Compound 20 | US10590109, Compound 15)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436194(US10590109, Compound 12)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436201(US10590109, Compound 19)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436193(US10590109, Compound 11)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent